1,4-Dioxane → 4-tert-butyl-N-{5-(4-methylphenyl)-6-(2-phenoxyethoxy)pyrimidin-4-yl}benzenesulfonamide

HRID 2279

반응식

HRID 2279 반응식
Br[C:2]1[CH:38]=[CH:37][C:5]([O:6][CH2:7][CH2:8][O:9][C:10]2[N:15]=[CH:14][N:13]=[C:12]([NH:16][S:17]([C:20]3[CH:25]=[CH:24][C:23]([C:26]([CH3:29])([CH3:28])[CH3:27])=[CH:22][CH:21]=3)(=[O:19])=[O:18])[C:11]=2[C:30]2[CH:35]=[CH:34][C:33]([CH3:36])=[CH:32][CH:31]=2)=[CH:4][CH:3]=1.[CH2:39]([O:41]C([Sn](CCCC)(CCCC)CCCC)=C)[CH3:40].O1C[CH2:61][O:60][CH2:59][CH2:58]1.[F-].[K+]>C(OCC)(=O)C.C1C=CC(P(C2C=CC=CC=2)C2C=CC=CC=2)=CC=1.C1C=CC(P(C2C=CC=CC=2)C2C=CC=CC=2)=CC=1.Cl[Pd]Cl>[C:26]([C:23]1[CH:22]=[CH:21][C:20]([S:17]([NH:16][C:12]2[C:11]([C:30]3[CH:35]=[CH:34][C:33]([CH3:36])=[CH:32][CH:31]=3)=[C:10]([O:9][CH2:8][CH2:7][O:6][C:5]3[CH:4]=[CH:3][CH:2]=[CH:38][CH:37]=3)[N:15]=[CH:14][N:13]=2)(=[O:19])=[O:18])=[CH:25][CH:24]=1)([CH3:29])([CH3:27])[CH3:28].[C:39]([C:2]1[CH:38]=[CH:37][C:5]([O:6][CH2:7][CH2:8][O:9][C:10]2[N:15]=[CH:14][N:13]=[C:12]([NH:16][S:17]([C:20]3[CH:25]=[CH:24][C:23]([C:26]([CH3:28])([CH3:27])[CH3:29])=[CH:22][CH:21]=3)(=[O:19])=[O:18])[C:11]=2[C:30]2[CH:35]=[CH:34][C:33]([CH3:36])=[CH:32][CH:31]=2)=[CH:4][CH:3]=1)(=[O:41])[CH3:40].[C:26]([C:23]1[CH:24]=[CH:25][C:20]([S:17]([NH:16][C:12]2[C:11]([C:30]3[CH:35]=[CH:34][C:33]([CH3:36])=[CH:32][CH:31]=3)=[C:10]([O:9][CH2:8][CH2:7][O:6][C:5]3[CH:37]=[CH:38][C:2]([C:61]([O:60][CH2:59][CH3:58])=[O:41])=[CH:3][CH:4]=3)[N:15]=[CH:14][N:13]=2)(=[O:19])=[O:18])=[CH:21][CH:22]=1)([CH3:29])([CH3:28])[CH3:27]

참가 물질

9

반응물 4

HCID 312751,4-DioxaneHCID 522689Potassium FluorideHCID 619414Stannane, tributyl(1-ethoxyethenyl)-HCID 19689478N-[6-{2-(4-bromophenoxy)ethoxy}-5-(4-methylphenyl)pyrimidin-4-yl]-4-tert-butylbenzenesulfonamide

생성물 3

HCID 196894604-tert-butyl-N-{5-(4-methylphenyl)-6-(2-phenoxyethoxy)pyrimidin-4-yl}benzenesulfonamideHCID 19689469N-[6-{2-(4-acetylphenoxy)ethoxy}-5-(4-methylphenyl)pyrimidin-4-yl]-4-tert-butylbenzenesulfonamideHCID 196895284-tert-butyl-N-[6-{2-(4-ethoxycarbonylphenoxy)ethoxy}-5-(4-methylphenyl)pyrimidin-4-yl]benzenesulfonamide

시약·촉매·용매 2

HCID 6102075Dichlorobis(triphenylphosphine)palladium촉매HCID 8857Ethyl Acetate용매

실험 절차

A mixture of N-[6-{2-(4-bromophenoxy)ethoxy}-5-(4-methylphenyl)pyrimidin-4-yl]-4-tert-butylbenzenesulfonamide (600 mg), (1-ethoxyvinyl)tributyltin (680 mg), bis(triphenylphosphine)palladium (II) chloride (35.5 mg) and dioxane (24 ml) is refluxed for 18 hours. The mixture is diluted with ethyl acetate, and thereto is added 10% aqueous potassium fluoride solution, and the precipitated crystals are removed by filtration. The filtrate is extracted with ethyl acetate, and the ethyl acetate layer is washed, dried, and concentrated to dryness under reduced pressure. The residue is purified by silica gel column chromatography (solvent; n-hexane/ethyl acetate=5:1~3:1~1:1), and the obtained compounds are each recrystallized from ethyl acetate/diisopropyl ether to give 4-tert-butyl-N-{5-(4-methylphenyl)-6-(2-phenoxyethoxy)pyrimidin-4-yl}benzenesulfonamide (Compound A) (42 mg), N-[6-{2-(4-acetylphenoxy)ethoxy}-5-(4-methylphenyl)pyrimidin-4-yl]-4-tert-butylbenzenesulfonamide (Compound B) (242 mg) and 4-tert-butyl-N-[6-{2-(4-ethoxycarbonylphenoxy)ethoxy}-5-(4-methylphenyl)pyrimidin-4-yl]benzenesulfonamide (Compound C) (58 mg), respectively.

후처리

  1. temperatureis refluxed for 18 hours
  2. customthe precipitated crystals are removed by filtration
  3. extractionThe filtrate is extracted with ethyl acetate
  4. washthe ethyl acetate layer is washed
  5. customdried
  6. concentrationconcentrated to dryness under reduced pressure
  7. customThe residue is purified by silica gel column chromatography (solvent; n-hexane/ethyl acetate=5:1~3:1~1:1)
  8. customeach recrystallized from ethyl acetate/diisopropyl ether

출처 및 근거

ORD 기록
ord-46a2349036204912b3e748e1dead945d
출처 데이터셋
uspto-grants-1998_03
특허 번호
US05728706

연결된 노트

불러오는 중…